Hot of the press: Our new publication featured in @NatureComms highlights how the @US_FDA -cleared elio™ tissue complete assay is a viable solution to bring the promise of #precisiononcology to patients with cancer.

The Labcorp Oncology team enjoyed our discussions at #AMP2022 this year. Thank you for stopping by to see our exhibit and attending our workshops highlighting the real-world customer experience of our kitted solutions that are helping to expedite cancer care.

Don't miss the webinar "Impact of Genomic Profiling on Risk Stratification and Treatment Selection in Acute Myeloid Leukemia" on Tuesday, November 29 at 1pm EST. Panelists will review clinical cases and host a Q&A. Register today: #precisiononcology #AML

RT @ESeversonMDPhD: Great turn out today at our @AMPath workshop today @AMPath. We reviewed how a simple blood draw from a patient with can….

Don't miss the webinar "Impact of Structural Variants and Co-Occurring Variants on Cancer Therapy Prioritization" on Tuesday, November 15 at 1pm EST. Panelists will review patient cases and host a Q&A. Register today: #precisiononcology

Join us for the "Therapeutic Case for Expanding Germline Cancer Risk Panels: Implications for HRD and Beyond" webinar on Tuesday, Nov. 1 at 1 p.m. EST. Panelists will review clinical cases and host a live Q&A. Register today: #precisiononcology #cancercare

Are you attending #AMP2022? Join our free workshops to learn how we are helping to democratize access to precision oncology for patients with cancer. Register here to save your seat and have a chance to win a door prize.

The co-approval of HER2 monoclonal antibody therapeutics and CDx raised the bar for #breastcancer therapies. Since then, we have been closely associated with pivotal studies in breast cancer with CDK4/6 and PARP inhibitors and biomarkers.

The Countdown for #AMP2022 has begun! We look forward to meeting you in person in Phoenix, AZ. Come to booth 1102 to discover how we are helping to deliver the promise of precision medicine to all patients.

Join us for the "Therapeutic Case for Expanding Germline Cancer Risk Panels: Implications for HRD and Beyond" webinar on Tuesday, Nov. 1 at 1 p.m. EST. Panelists will review clinical cases and host a live Q&A. Register today: #precisiononcology #cancercare

PGDx is now part of @Labcorp. Be sure to follow Labcorp to stay up-to-date on the latest #oncology updates. We look forward to providing timely and relevant information about how we are driving precision cancer care forward:

October is breast cancer awareness month. From a single breast biopsy, OmniSeq INSIGHT® can help oncologists identify targeted treatment options for patients with breast cancer. #BreastCancerAwarenessMonth

Join us for the "Multiomic Analyses and Cancer Therapy Selection" webinar on Tuesday, Oct. 18 at 1 p.m. EST. Panelists will review patient cases and host a live Q&A. Register today: .#precisiononcology #biomarkers

RT @Labcorp: Thank you to the many #oncology scientists who showcased the breadth and depth of our clinical diagnostics and research innova….

RT @Labcorp: Dr. Prasanth Reddy, SVP and Global Head of Enterprise Oncology, recently shared his views on how Labcorp is working with cance….

RT @Labcorp: Over 1.5 million people in the U.S. are living with or in remission from #leukemia, #lymphoma, #myeloma, #MDS or #MPN. Labcorp….

RT @Labcorp: Chairman and CEO @AdamHSchechter has been nominated for @modrnhealthcr's 100 Most Influential People in Healthcare award. We….

RT @Labcorp: It is estimated 15,950 children and adolescents will be diagnosed with cancer this year. During #ChildhoodCancerAwareness mont….

RT @Labcorp: We’re dedicated to helping providers improve access to healthcare through new diagnostic tools. With liquid biopsy, providers….